市場調查報告書
商品編碼
956123

帕金森氏症的腦深部刺激療法- 全球市場的展望(2019年∼2027年)

Deep Brain Stimulation in Parkinson's Disease - Global Market Outlook (2019-2027)

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 192 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

帕金森氏症的全球深層腦刺激療法市場在預測期內將保持10.5%的複合年增長率,市場規模預計將從2019年的677.89億美元增長到2027年的159.07萬美元。帕金森氏症(PD)等神經系統疾病的發病率以及政府政策和法律的不斷增加是市場增長的主要動力。但是,外科手術的副作用正在減緩市場增長。

本報告提供全球帕金森氏症的腦深部刺激療法的市場調查,彙整市場及產品概要,對市場成長的各種影響因素及市場機會分析,產品·終端用戶·地區/主要國家等各種區分趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 簡介
  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 產品分析
  • 終端用戶分析
  • 新興市場
  • Covid-19的影響

第4章 波特的五力分析

第5章 全球帕金森氏症的腦深部刺激療法市場:各產品

  • 雙通道深腦刺激器
  • 單通道深腦刺激器

第6章 全球帕金森氏症的腦深部刺激療法市場:各終端用戶

  • 門診病人手術中心(ASC)
  • 醫院
  • 神經學診所
  • 調查中心

第7章 全球帕金森氏症的腦深部刺激療法市場:各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他

第8章 主要發展

  • 契約,聯盟,合作,合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他主要策略

第9章 企業簡介

  • Abbott
  • Aleva Neurotherapeutics SA
  • Beijing PINS Medical Co
  • Boston Scientific Corporation
  • Functional Neuromodulation Ltd
  • Medtronic
  • Neuronetics Inc
  • NeuroPace Inc
  • Nevro Corporation
目錄

According to Stratistics MRC, the Global Deep Brain Stimulation in Parkinson's Disease Market is accounted for $678.89 million in 2019 and is expected to reach $1,509.07 million by 2027 growing at a CAGR of 10.5% during the forecast period. Increasing incidence of neurological disorders, such as Parkinson's disease (PD) and supportive government policies and laws of the countries are the major factors driving the market growth. However, a surgical side effect is restraining the market growth.

Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of a medical device called a neurostimulator (sometimes referred to as a "brain pacemaker"), which sends electrical impulses, through implanted electrodes, to specific targets in the brain. DBS is used to manage some of the symptoms of Parkinson's Disease that cannot be adequately controlled with medications. It is recommended for people who have PD with motor fluctuations and tremor inadequately controlled by medication, or to those who are intolerant to medication, as long as they do not have severe neuropsychiatric problems.

Based on end user, the ambulatory surgical centers (ASCs) segment is likely to have a huge demand due to several advantages offered by ASCs, such as shorter procedure time and same-day discharge as compared to the hospitals. Moreover, most of the neurosurgeries can now be performed at ASCs as surgical procedures turn out to be more advanced and less invasive. By geography, North America is going to have a lucrative growth during the forecast period due to increase in prevalence of psychological disorders, rise in awareness about treatments, availability of highly skilled physicians, and presence of well-established healthcare facilities. Furthermore, rising adoption of technologically advanced medical devices and rise in the demand for minimally invasive procedures are expected to boost the growth of DBS devices market in this region.

Some of the key players profiled in the Deep Brain Stimulation in Parkinson's Disease Market include Abbott, Aleva Neurotherapeutics SA, Beijing PINS Medical Co, Boston Scientific Corporation, Functional Neuromodulation Ltd, Medtronic, Neuronetics Inc, NeuroPace Inc and Nevro Corporation.

Products Covered:

  • Dual Channel Deep Brain Stimulator
  • Single Channel Deep Brain Stimulator

End Users Covered:

  • Ambulatory Surgical Centers (ASCs)
  • Hospitals
  • Neurology Clinics
  • Research Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Deep Brain Stimulation in Parkinson's Disease Market, By Product

  • 5.1 Introduction
  • 5.2 Dual Channel Deep Brain Stimulator
  • 5.3 Single Channel Deep Brain Stimulator

6 Global Deep Brain Stimulation in Parkinson's Disease Market, By End User

  • 6.1 Introduction
  • 6.2 Ambulatory Surgical Centers (ASCs)
  • 6.3 Hospitals
  • 6.4 Neurology Clinics
  • 6.5 Research Centers

7 Global Deep Brain Stimulation in Parkinson's Disease Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Abbott
  • 9.2 Aleva Neurotherapeutics SA
  • 9.3 Beijing PINS Medical Co
  • 9.4 Boston Scientific Corporation
  • 9.5 Functional Neuromodulation Ltd
  • 9.6 Medtronic
  • 9.7 Neuronetics Inc
  • 9.8 NeuroPace Inc
  • 9.9 Nevro Corporation

List of Tables

  • Table 1 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Region (2018-2027) ($MN)
  • Table 2 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
  • Table 3 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 4 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 5 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End User (2018-2027) ($MN)
  • Table 6 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
  • Table 7 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 8 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
  • Table 9 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
  • Table 10 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
  • Table 11 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
  • Table 12 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 13 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 14 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End User (2018-2027) ($MN)
  • Table 15 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
  • Table 16 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 17 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
  • Table 18 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
  • Table 19 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
  • Table 20 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
  • Table 21 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 22 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 23 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End User (2018-2027) ($MN)
  • Table 24 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
  • Table 25 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 26 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
  • Table 27 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
  • Table 28 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
  • Table 29 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
  • Table 30 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 31 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 32 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End User (2018-2027) ($MN)
  • Table 33 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
  • Table 34 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 35 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
  • Table 36 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
  • Table 37 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
  • Table 38 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
  • Table 39 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 40 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 41 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End User (2018-2027) ($MN)
  • Table 42 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
  • Table 43 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 44 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
  • Table 45 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
  • Table 46 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
  • Table 47 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
  • Table 48 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 49 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
  • Table 50 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End User (2018-2027) ($MN)
  • Table 51 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
  • Table 52 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 53 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
  • Table 54 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)